225 related articles for article (PubMed ID: 12942141)
21. The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling.
Sutton LP; Rushlow WJ
Neuroscience; 2011 Dec; 199():116-24. PubMed ID: 22001305
[TBL] [Abstract][Full Text] [Related]
22. The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters.
Di Daniel E; Cheng L; Maycox PR; Mudge AW
Mol Cell Neurosci; 2006; 32(1-2):27-36. PubMed ID: 16531065
[TBL] [Abstract][Full Text] [Related]
23. Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure.
Eickholt BJ; Towers GJ; Ryves WJ; Eikel D; Adley K; Ylinen LM; Chadborn NH; Harwood AJ; Nau H; Williams RS
Mol Pharmacol; 2005 May; 67(5):1426-33. PubMed ID: 15687223
[TBL] [Abstract][Full Text] [Related]
24. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.
Gould TD; Manji HK
Neuropsychopharmacology; 2005 Jul; 30(7):1223-37. PubMed ID: 15827567
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine.
Roh MS; Eom TY; Zmijewska AA; De Sarno P; Roth KA; Jope RS
Biol Psychiatry; 2005 Feb; 57(3):278-86. PubMed ID: 15691529
[TBL] [Abstract][Full Text] [Related]
26. Cytoprotection by lithium and valproate varies between cell types and cellular stresses.
Lai JS; Zhao C; Warsh JJ; Li PP
Eur J Pharmacol; 2006 Jun; 539(1-2):18-26. PubMed ID: 16678157
[TBL] [Abstract][Full Text] [Related]
27. Lithium treatment enhances estradiol-induced proliferation and hyperplasia formation in the uterus of mice.
Gunin AG; Emelianov VU; Mironkin IU; Morozov MP; Tolmachev AS
Eur J Obstet Gynecol Reprod Biol; 2004 May; 114(1):83-91. PubMed ID: 15099877
[TBL] [Abstract][Full Text] [Related]
28. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP.
Benedetti F; Serretti A; Pontiggia A; Bernasconi A; Lorenzi C; Colombo C; Smeraldi E
Neurosci Lett; 2005 Mar; 376(1):51-5. PubMed ID: 15694273
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
[TBL] [Abstract][Full Text] [Related]
30. Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks.
Padiath QS; Paranjpe D; Jain S; Sharma VK
Chronobiol Int; 2004 Jan; 21(1):43-55. PubMed ID: 15129823
[TBL] [Abstract][Full Text] [Related]
31. A cellular assay for measuring the inhibition of glycogen synthase kinase-3 via the accumulation of beta-catenin in Chinese hamster ovary clone K1 cells.
Yeow K; Novo-Perez L; Gaillard P; Page P; Gotteland JP; Scheer A; Lang P
Assay Drug Dev Technol; 2006 Aug; 4(4):451-60. PubMed ID: 16945017
[TBL] [Abstract][Full Text] [Related]
32. Effect of Imipramine, Paroxetine, and Lithium Carbonate on Neurobehavioral Changes of Streptozotocin in Rats: Impact on Glycogen Synthase Kinase-3 and Blood Glucose Level.
Nadeem RI; Ahmed HI; El-Denshary EE
Neurochem Res; 2015 Sep; 40(9):1810-8. PubMed ID: 26216050
[TBL] [Abstract][Full Text] [Related]
33. GSK-3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid.
Jonathan Ryves W; Dalton EC; Harwood AJ; Williams RS
Bipolar Disord; 2005 Jun; 7(3):260-5. PubMed ID: 15898963
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth.
Mazor M; Kawano Y; Zhu H; Waxman J; Kypta RM
Oncogene; 2004 Oct; 23(47):7882-92. PubMed ID: 15361837
[TBL] [Abstract][Full Text] [Related]
35. Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing.
Su Y; Ryder J; Li B; Wu X; Fox N; Solenberg P; Brune K; Paul S; Zhou Y; Liu F; Ni B
Biochemistry; 2004 Jun; 43(22):6899-908. PubMed ID: 15170327
[TBL] [Abstract][Full Text] [Related]
36. Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus.
Cardona-Gomez P; Perez M; Avila J; Garcia-Segura LM; Wandosell F
Mol Cell Neurosci; 2004 Mar; 25(3):363-73. PubMed ID: 15033165
[TBL] [Abstract][Full Text] [Related]
37. Lithium induces morphological differentiation of mouse neuroblastoma cells.
García-Pérez J; Avila J; Díaz-Nido J
J Neurosci Res; 1999 Jul; 57(2):261-70. PubMed ID: 10398304
[TBL] [Abstract][Full Text] [Related]
38. β-catenin promoter ChIP-chip reveals potential schizophrenia and bipolar disorder gene network.
Pedrosa E; Shah A; Tenore C; Capogna M; Villa C; Guo X; Zheng D; Lachman HM
J Neurogenet; 2010 Dec; 24(4):182-93. PubMed ID: 20615089
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotective and neurotrophic effects of long term lithium treatment in mouse brain.
Riadh N; Allagui MS; Bourogaa E; Vincent C; Croute F; Elfeki A
Biometals; 2011 Aug; 24(4):747-57. PubMed ID: 21373826
[TBL] [Abstract][Full Text] [Related]
40. Regulation of glycogen synthase kinase-3 in patients with affective disorders.
O'Brien WT; Klein PS
Biol Psychiatry; 2007 Jan; 61(2):139-41. PubMed ID: 17223440
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
